CD163 and metabolic dysfunction-associated steatotic liver disease: A significant portion of sCD163 is potentially derived from Kupffer cells, as sCD163-concentrations are found to be 23% higher in the hepatic vein, as compared to the portal vein, in patients with obesity or NAFLD (130).